Showing results (1531-1540 of 1,768) with videos related to
Sort By:
Pageof 177
International Journal of Food Microbiology|March 7, 2014
Influence of different proteolytic strains of Streptococcus thermophilus in co-culture with Lactobacillus delbrueckii subsp. bulgaricus on the metabolite profile of set-yoghurtSarn Settachaimongkon, M J Robert Nout, Elsa C Antunes Fernandes, et al.Plos Genetics|March 2, 2017
TFAP2 paralogs regulate melanocyte differentiation in parallel with MITFHannah E Seberg, Eric Van Otterloo, Stacie K Loftus, et al.Diabetes & Metabolism|December 17, 2013
Ketoacidosis at diagnosis of type 1 diabetes in French children and adolescentsC Choleau, J Maitre, A Filipovic Pierucci, et al.Nature Chemical Biology|August 11, 2014
A new mechanism of allostery in a G protein-coupled receptor dimerJ Robert Lane, Prashant Donthamsetti, Jeremy Shonberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology GroupAmye J Tevaarwerk, Molin Wang, Fengmin Zhao, et al.Bioorganic & Medicinal Chemistry Letters|May 4, 2017
Optimization of a binding fragment targeting the "enlarged methionine pocket" leads to potent Trypanosoma brucei methionyl-tRNA synthetase inhibitorsWenlin Huang, Zhongsheng Zhang, Ranae M Ranade, et al.The New England Journal of Medicine|April 15, 1999
Clinical features of 52 neonates with hyperinsulinismP de Lonlay-Debeney, F Poggi-Travert, J C Fournet, et al.Journal of Medicinal Chemistry|January 20, 2023
Dopamine D<sub>3</sub>/D<sub>2</sub> Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective DisordersEmma S Gogarnoiu, Caleb D Vogt, Julie Sanchez, et al.Human Pathology|February 17, 2007
Neonatal hyperinsulinism: clinicopathologic correlationP Delonlay, A Simon, L Galmiche-Rolland, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancerNicholas J Robert, Véronique Diéras, John Glaspy, et al.Pageof 177